2020
DOI: 10.1016/j.lrr.2020.100200
|View full text |Cite|
|
Sign up to set email alerts
|

Successful Treatment of Ocular Chronic Lymphocytic Leukemia with Ibrutinib: Case Report and Review of the Literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 35 publications
0
3
0
Order By: Relevance
“…Current treatment options include high-dose systemic steroids, external beam radiation therapy, laser photocoagulation, and chemoimmunotherapy. 16 Certain ocular manifestations, such as conjunctival infiltration, are reported to respond better to systemic chemotherapy. 21 Leukemia cutis lesions have been shown to resolve after systemic treatment of CLL or local radiation.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Current treatment options include high-dose systemic steroids, external beam radiation therapy, laser photocoagulation, and chemoimmunotherapy. 16 Certain ocular manifestations, such as conjunctival infiltration, are reported to respond better to systemic chemotherapy. 21 Leukemia cutis lesions have been shown to resolve after systemic treatment of CLL or local radiation.…”
Section: Discussionmentioning
confidence: 99%
“…2 Neuroimaging by MRI has a lower sensitivity (29%) for detecting meningeal involvement from leukemia or lymphoma compared with cerebrospinal fluid cytology (96.8%). 16 The yield of vitreous biopsy for intraocular CLL involvement is unknown, although in general there is a high false negative yield due to the low tumor burden. Biopsy and immunohistochemical study of the skin or orbital tissue may be helpful in cases where vitreous sampling was unrevealing.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation